Literature DB >> 46593

Ir-gene control of immunogenicity of insulin and A-chain loop as a carrier determinant.

K Keck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46593     DOI: 10.1038/254078a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  19 in total

Review 1.  Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity.

Authors:  Peter E Jensen; Barbara A Sullivan; Lisa M Reed-Loisel; Dominique A Weber
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Immune response genes have a variable influence on the selection of antigenic foreign and self determinants of insulin.

Authors:  I R Cohen; J Talmon; V Lev-Ram; A Ben-Nun
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  NFATc2 (NFAT1) assists BCR-mediated anergy in anti-insulin B cells.

Authors:  Rachel H Bonami; William T Wolfle; James W Thomas; Peggy L Kendall
Journal:  Mol Immunol       Date:  2014-02-06       Impact factor: 4.407

Review 4.  Precise determination of protein antigenic structures has unravelled the molecular immune recognition of proteins and provided a prototype for synthetic mimicking of other protein binding sites.

Authors:  M Z Atassi
Journal:  Mol Cell Biochem       Date:  1980-08-29       Impact factor: 3.396

Review 5.  Function of macrophages as antigen presenting cells.

Authors:  J Schroer; A S Rosenthal
Journal:  Springer Semin Immunopathol       Date:  1980-08

6.  Structural analysis of insulin determinants seen by T cells directed by H-2 genes.

Authors:  J Talmon; G Ranghino; A Yonath; I R Cohen
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  Thymic reconstitution of H-2-linked T-cell responses to thyroglobulin or insulin.

Authors:  R Maron; I R Cohen
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  Immunological properties and biological effectiveness of insulin analogues substituted at position B30.

Authors:  H P Neubauer; R Obermeier; G Schnorr
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

9.  In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.

Authors:  D L Mann; N Mendell; C R Kahn; A H Johnson; A Rosenthal
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

10.  The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model.

Authors:  J L Ottesen; P Nilsson; J Jami; D Weilguny; M Dührkop; D Bucchini; S Havelund; J M Fogh
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.